Siga, Japan

Hidenobu Kubota

This inventor holds 1 USPTO granted patent. Top assignee: Toray Industries, Inc.. Active years: 1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidenobu Kubota. Retrieved from https://idiyas.com/inventor/hidenobu-kubota

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hidenobu Kubota: Innovator in Interferon Production

Introduction

Hidenobu Kubota is a notable inventor based in Siga, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of interferon. His innovative approach has garnered attention in the scientific community.

Latest Patents

Hidenobu Kubota holds a patent for a process for producing interferon. This process involves treating animal cells proliferated on a microcarrier with an interferon inducer. The unique aspect of his method is the treatment of the cells on the microcarrier with a negatively charged water-soluble macromolecular material. This innovation has the potential to enhance the efficiency of interferon production.

Career Highlights

Kubota is associated with Toray Industries, Inc., a leading company in the field of advanced materials and biotechnology. His work at Toray has allowed him to focus on groundbreaking research and development in the production of therapeutic proteins.

Collaborations

Hidenobu Kubota has collaborated with notable colleagues such as Masahiko Iizuka and Emiko Sano. These partnerships have contributed to the advancement of his research and the successful implementation of his patented processes.

Conclusion

Hidenobu Kubota's contributions to the field of biotechnology, particularly in interferon production, highlight his innovative spirit and dedication to scientific advancement. His work continues to influence the industry and pave the way for future developments in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…